Android Apple

Cg Oncology Inc. (CGON): Short Seller Sentiment is Bearish on This Cancer Stock

By Yahoo! Finance   |   3 months ago
Cg Oncology Inc. (CGON): Short Seller Sentiment is Bearish on This Cancer Stock

Cg Oncology Inc. (NASDAQ:CGON) is a company focusing on bladder-sparing treatments for bladder cancer patients. Analysts are optimistic about its drug candidate, cretostimogene, with a projected global sales of over $2 billion by 2033.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.